Diverse pathogenic microorganisms

Diverse pathogenic microorganisms encompass a wide array of infectious agents, including bacteria, viruses, fungi, and protozoa, that are capable of causing disease in humans and other hosts [1]. These organisms are characterized by their ability to invade host tissues, evade the immune system, and replicate, leading to clinical manifestations of infection [2]. Rather than being a single molecular target, this term represents a collective group of biological entities that are the focus of anti-infective therapy. Drugs such as antibiotics, antivirals, and antifungals interact with specific components within these microorganisms, such as cell wall enzymes, ribosomes, or polymerases, to exert their effects [3]. The primary therapeutic goal is to achieve selective toxicity, where the drug harms the pathogen without significantly affecting the host [4]. A major global health challenge associated with these microorganisms is the emergence of antimicrobial resistance, which occurs when pathogens evolve mechanisms to survive exposure to drugs [5]. Consequently, drug development often focuses on identifying novel, conserved targets within these diverse groups to overcome resistance patterns.

Other names

PathogensInfectious agentsMicrobesGerms

Inhibition of cell wall synthesis, inhibition of protein synthesis, inhibition of nucleic acid replication, and disruption of cell membrane integrity [3, 4]